Image Source: AsiaOne
Clover Signs COVID-19 Vaccine Supply Agreement with UNICEFGlobeNewswireDecember 07, 2021CHENGDU, China, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; Stock code: 2197.HK), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that they have entered into a long-term agreement (LTA) with UNICEF for Clover to supply its COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), to the COVAX Facility.
Source: AsiaOne